Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 21, Number 10—October 2015
Research

Induction of Multidrug Tolerance in Plasmodium falciparum by Extended Artemisinin Pressure

Sandie Ménard, Tanila Ben Haddou, Arba Pramundita Ramadani1, Frédéric Ariey, Xavier Iriart, Johann Beghain, Christiane Bouchier, Benoit Witkowski2, Antoine Berry, Odile Mercereau-Puijalon, and Françoise Benoit-VicalComments to Author 
Author affiliations: Université de Toulouse, Toulouse, France (S. Ménard, T. Ben Haddou, A.P. Ramadani, X. Iriart, B. Witkowski, A. Berry, F. Benoit-Vical); Centre de Physiopathologie de Toulouse-Purpan, Toulouse (S. Ménard. X. Iriart, A. Berry); Laboratoire de Chimie de Coordination du Centre National de la Recherche Scientifique, Toulouse (T. Ben Haddou, A.P. Ramadani, B. Witkowski, F. Benoit-Vical); Institut Pasteur, Paris, France (F. Ariey, J. Beghain, C. Bouchier, O. Mercereau-Puijalon); Centre Hospitalier Universitaire de Toulouse, Toulouse (X. Iriart, A. Berry)

Main Article

Table 3

Recrudescence parameters of Plasmodium falciparum F32-ART5 and F32-TEM lineages exposed to 10 antimalarial drugs*

Drug Drug dose No. experiments† Median (range) recrudescence time, d‡
Mean ± SEM difference of recrudescence time, d¶ p value‡
F32-ART5 F32-TEM§
Artemisinin
11 µmol/L 7 8 (6–11) 22 (15–>28) 11.5 ± 1.5 <0.001
18 µmol/L
3
7 (6–9)
19 (17–20)
11.3 ± 1.3
0.024
Artesunate
1.3 µmol/L 3 8 (7–10) 16 (15–18) 8 ± 1.5 0.024
2.6 µmol/L
3
8 (7–10)
16 (15–18)
8 ± 1.5
0.024
Artemisone
1.2 µmol/L 3 8 (7–10) 20 (18–20) 11 ± 1.5 0.024
2.5 µmol/L
3
8 (7–11)
21 (20–28)
14.3 ± 1.4
0.025
Artemether
1.7 µmol/L 2 7.5 (7–8) 15 (15–15) 7.5 ± 0.5 0.089
3.4 µmol/L
2
7.5 (7–8)
16 (16–16)
8.5 ± 0.5
0.089
Chloroquine
78 nmol/L
4
10 (7–11)
13 (11–20)
4.8 ± 1.5
0.028
Quinine
43 µmol/L
5
10 (8–14)
13 (10–>20)
2.7 ± 0.9
0.086
Amodiaquine
62 nmol/L
4
7.5 (7–9)
14.5 (12–16)
6 ± 0.6
0.006
Mefloquine
241 nmol/L
5
8 (6–12)
11 (10–>20)
3 ± 1.1
0.044
Pyrimethamine
4 µmol/L
5
5 (5–7)
9 (7–10)
3 ± 0.5
0.008
Atovaquone 3 µmol/L 5 13 (3–27) 12 (3–21) −1.4 ± 1.3 0.730
7 µmol/L 4 14.5 (11–18) 13 (11–19) −0.5 ± 0.6 0.848

*Recrudescence capacity of F32-TEM and F32-ART5, synchronized at ring-form cultures (0–12-h-old parasites), was evaluated after 48 h of drug treatment. After cultures were washed, parasitemia was monitored daily to determine the recrudescence time, defined as the time to reach day 0 parasitemia.
†Each experiment was performed for F32-ART and F32-TEM cultivated in parallel in the same conditions (adjusted to the same initial parasitemia and cultivated with the same lot of erythrocytes and same batch of human serum) to generate paired results. The same number of experiments was performed for each parasite lineage and statistically analyzed.
‡A log-rank (Mantel-Cox) test was used for statistical analysis of recrudescence time in days.
§If no parasites were observed at the end of the experiment, the culture was classified as showing no recrudescence, and the recrudescence day was noted as >d. Parasite counts were monitored microscopically daily until day 28 except when the batch of blood needed to be changed (in this instance, the experiment was stopped earlier).
¶Differences in recrudescence time as Gaussian data.

Main Article

1Current affiliation: Universitas Gadjah Mada, Yogyakarta, Indonesia.

2Current affiliation: Institut Pasteur, Phnom Penh, Cambodia.

Page created: September 22, 2015
Page updated: September 22, 2015
Page reviewed: September 22, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external